Skip to main content
Premium Trial:

Request an Annual Quote

US Biological, Akrivis to Co-develop Research Products

NEW YORK (GenomeWeb News) – Akrivis Technologies today said that it has inked an agreement with United States Biological to co-develop, manufacture, and sell research products based on Akrivis' Z-Tect technology.

The Z-Tect technology is a nanotechnology-based technique for detecting unusually low levels of protein and molecular targets. According to the firms, the technology has "ultra-low limits of detection several thousand fold lower than currently achievable," and will make it possible to "vastly improve the early detection of cancer biomarkers in vitro."

"As we progress towards developing ultrasensitive clinical diagnostics, this agreement provides Akrivis with US Biological's extensive US and international sales and distribution channels for the broad and imminent commercialization of its Z-Tect ultrasensitive detection platform for research use," Joel Berniac, CEO of Cambridge, Mass.-based Akrivis Technologies, said in a statement. "In addition, Akrivis and US Biological will co-develop new ultrasensitive kits based on US Biological's extensive catalog of biomolecular targets, biomarkers and antibodies, covering the oncology, CNS, cardiovascular, inflammation, and auto-immune therapeutic areas."

Salem, Mass.-based US Biological is a provider of antibodies, molecular biology products, and biochemicals used in research laboratories and production facilities.

Financial and further terms of the alliance were not disclosed.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.